中国循证心血管医学杂志
中國循證心血管醫學雜誌
중국순증심혈관의학잡지
CHINESE JOURNAL OF EVIDENCE-BASES CARDIOVASCULAR MEDICINE
2013年
5期
489-491
,共3页
杨勇%刘惠亮%杨胜利%刘英%沈志奇
楊勇%劉惠亮%楊勝利%劉英%瀋誌奇
양용%류혜량%양성리%류영%침지기
阿托伐他汀%ST段抬高型急性心肌梗死%超敏C反应蛋白%NO合酶%ST段回落指数
阿託伐他汀%ST段抬高型急性心肌梗死%超敏C反應蛋白%NO閤酶%ST段迴落指數
아탁벌타정%ST단태고형급성심기경사%초민C반응단백%NO합매%ST단회락지수
Atorvastatin%ST-segment elevation myocardial infarction%High sensitivity C-reactive protein%NO synthase%ST-segment resolution index
目的:探讨急诊经皮冠状动脉介入术(PCI)术前阿托伐他汀强化治疗对ST段抬高心肌梗死(STEMI)患者术后ST段回落、血清炎症因子及内皮功能的影响。方法纳入2010年3月~2010年12月武警总医院发病时间<12 h、拟行急诊PCI的STEMI患者95例,按照随机信封法随机分为3组:A组(n=34,术前给予负荷剂量阿托伐他汀80 mg,术后给予阿托伐他汀40 mg/d);B组(n=34,术前不服用他汀类药物,术后给予阿托伐他汀40 mg/d);C组(n=30,术前不服用他汀类药物,术后给予常规剂量阿托伐他汀20 mg/d),观察术后90 min内ST段回落情况以及术后24 h、3 d、7 d高敏C反应蛋白(hs-CRP)及NO合酶(NOS)的变化情况。结果术后90 min内A组ST段回落比例更高,同时回落幅度也更大,与B组和C组均有统计学差异(P<0.05);术后24 h,A组高敏C反应蛋白(hs-CRP)水平下降,但与B组和C组无统计学差异;术后3 d和7 d,A组hs-CRP进一步下降,且与B组和C组达到统计学差异(P<0.05);术后24 h及术后3 d,A组一氧化氮合成酶(NOS)水平高于B组和C组,但与B组和C组比较无统计学差异(P>0.05);术后7 d,A组NOS水平继续升高,与B组和C组达到统计学差异(P<0.05)。结论急诊PCI术前一次性给予大剂量(80 mg)阿托伐他汀强化治疗有利于STEMI患者心肌灌注恢复,并能够降低炎症反应,改善血管内皮功能。
目的:探討急診經皮冠狀動脈介入術(PCI)術前阿託伐他汀彊化治療對ST段抬高心肌梗死(STEMI)患者術後ST段迴落、血清炎癥因子及內皮功能的影響。方法納入2010年3月~2010年12月武警總醫院髮病時間<12 h、擬行急診PCI的STEMI患者95例,按照隨機信封法隨機分為3組:A組(n=34,術前給予負荷劑量阿託伐他汀80 mg,術後給予阿託伐他汀40 mg/d);B組(n=34,術前不服用他汀類藥物,術後給予阿託伐他汀40 mg/d);C組(n=30,術前不服用他汀類藥物,術後給予常規劑量阿託伐他汀20 mg/d),觀察術後90 min內ST段迴落情況以及術後24 h、3 d、7 d高敏C反應蛋白(hs-CRP)及NO閤酶(NOS)的變化情況。結果術後90 min內A組ST段迴落比例更高,同時迴落幅度也更大,與B組和C組均有統計學差異(P<0.05);術後24 h,A組高敏C反應蛋白(hs-CRP)水平下降,但與B組和C組無統計學差異;術後3 d和7 d,A組hs-CRP進一步下降,且與B組和C組達到統計學差異(P<0.05);術後24 h及術後3 d,A組一氧化氮閤成酶(NOS)水平高于B組和C組,但與B組和C組比較無統計學差異(P>0.05);術後7 d,A組NOS水平繼續升高,與B組和C組達到統計學差異(P<0.05)。結論急診PCI術前一次性給予大劑量(80 mg)阿託伐他汀彊化治療有利于STEMI患者心肌灌註恢複,併能夠降低炎癥反應,改善血管內皮功能。
목적:탐토급진경피관상동맥개입술(PCI)술전아탁벌타정강화치료대ST단태고심기경사(STEMI)환자술후ST단회락、혈청염증인자급내피공능적영향。방법납입2010년3월~2010년12월무경총의원발병시간<12 h、의행급진PCI적STEMI환자95례,안조수궤신봉법수궤분위3조:A조(n=34,술전급여부하제량아탁벌타정80 mg,술후급여아탁벌타정40 mg/d);B조(n=34,술전불복용타정류약물,술후급여아탁벌타정40 mg/d);C조(n=30,술전불복용타정류약물,술후급여상규제량아탁벌타정20 mg/d),관찰술후90 min내ST단회락정황이급술후24 h、3 d、7 d고민C반응단백(hs-CRP)급NO합매(NOS)적변화정황。결과술후90 min내A조ST단회락비례경고,동시회락폭도야경대,여B조화C조균유통계학차이(P<0.05);술후24 h,A조고민C반응단백(hs-CRP)수평하강,단여B조화C조무통계학차이;술후3 d화7 d,A조hs-CRP진일보하강,차여B조화C조체도통계학차이(P<0.05);술후24 h급술후3 d,A조일양화담합성매(NOS)수평고우B조화C조,단여B조화C조비교무통계학차이(P>0.05);술후7 d,A조NOS수평계속승고,여B조화C조체도통계학차이(P<0.05)。결론급진PCI술전일차성급여대제량(80 mg)아탁벌타정강화치료유리우STEMI환자심기관주회복,병능구강저염증반응,개선혈관내피공능。
Objective To investigate the influences of pre-operation intensive treatment of atorvastatin (80 mg) on post-operation ST-segment resolution index (STRI), serum inflammatory factors and endothelial function in the patients with ST-segment elevation myocardial infarction (STEMI). Methods The STEMI patients (n=95, onset<12 h) who planed accepting emergency PCI were chosen from the General Hospital of Chinese People’ s Armed Police Forces from Mar. 2010 to Dec. 2010, and randomly divide into group A (n=34, 80 mg atorvastatin before PCI and 40 mg/d after PCI), group B (n=34, no atorvastatin before PCI and 40 mg/d after PCI) and group C (n=30, no atorvastatin before PCI and 20 mg/d after PCI). The changes of STRI within 90 min after PCI, and high sensitivity C-reactive protein (hs-CRP) and NO synthase (NOS) after PCI for 24 h, 3 d and 7 d were observed. Results Within 90 min after PCI, the percentage and extent of ST-segment resolution were higher in group A compared with those in group B and group C (P<0.05). After PCI for 24 h, the level of hs-CRP decreased in group A, which had no statistical difference compared with group B and group C. After PCI for 3 d and 7 d, the level of hs-CRP decreased further in group A, which had statistical difference compared with group B and group C (P<0.05). After PCI for 24 h and 3 d, the level of NOS was higher in group A than that in group B and group C, which had no statistical difference (P>0.05). After PCI for 7 d, the level of NOS increased continuously in group A, which had statistical difference compared with group B and group C (P<0.05). Conclusion The one-time administration of high-dose atorvastatin (80 mg) before emergency PCI is benefit to alleviate the myocardial perfusion and inflammatory reactions, and improve vascular endothelial function in STEMI patients.